Drug Shortage Report for TEVA-LISINOPRIL (TYPE P)

Last updated on 2017-05-10 History
Report ID 2312
Drug Identification Number 02285061
Brand name TEVA-LISINOPRIL (TYPE P)
Common or Proper name LISINOPRIL P
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LISINOPRIL
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2017-04-01
Actual start date
Estimated end date 2017-04-27
Actual end date 2017-05-04
Shortage status Resolved
Updated date 2017-05-10
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2017-05-10 French Compare
v4 2017-05-10 English Compare
v3 2017-04-02 English Compare
v2 2017-03-14 French Compare
v1 2017-03-14 English Compare